Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease

References

• Kawasaki T. Acute febrile mucocutaneous syndrome with lym-phoid involvement with specific desquamation of the fingers and toes in children: clinical observation of 50 cases. Jpn J Allergy 1967;16:178–222.
   PubMedGoogle Scholar
• Cassidy JT, Petty RE. Kawasaki disease. In: Cassidy JT, Petty RE, eds. Textbook of pediatric rheumatology. 4th edn. Philadelphia: Saunders; 2001. p. 580–94.
   Google Scholar
• Suzuki A, Kamiya T, Kuwahara N, Ono Y, Kohata T, Takahashi 0, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 1986;7: 3–9.
   Google Scholar
• Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. High-dose intravenous gamma-globulin for Kawasaki disease. Lancet 1984;2:1055–8.
   PubMed Web of Science ®Google Scholar
• Leung DY, Costran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial cell activation and interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1986;2: 1298–302.
   Google Scholar
• Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necro-sis factor, interleukin-2 receptor, and interferon-y in Kawasaki disease involved coronary lesions. Chin Immunol Immunopathol 1990;56: 29–36.
   Google Scholar
• Niwa Y, Shomiya K. Enhanced neutrophilic functions in mucocu-taneous lymph node syndrome, with special reference to the pos-sible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritis. J Pediatr 1984;104:56–60.
   PubMedGoogle Scholar
• Terai M, Kohno Y, Namba M, Umemiya T, Niwa K, Nakajima H, et al. Class II major histocompatibility antigen expression on coro-nary arterial endothelium in a patient with Kawasaki disease. Hum Pathol 1990;21:231–4.
   PubMedGoogle Scholar
• Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, et al. Selective high-dose gamma-globulin treatment in Kawasaki dis-ease: assessment of clinical aspects and cost effectiveness. Pediatr Int 1999;41:1–7.
   PubMedGoogle Scholar
• Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633–9.
   PubMed Web of Science ®Google Scholar
• Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 1997;131:888–93.
   PubMed Web of Science ®Google Scholar
• Arjunan K, Daniels SR, Meyer RA. Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study. J Am Coll Cardiol 1986;8:1119–24.
   Google Scholar
• Agresti A. An introduction to categorical data analysis. Tokyo: Wiley; 1996.
   Google Scholar
• Barron KS, Murphy DJ, Silverman ED, Ruttenberg HD, Wright GB, Franklin W, et al. Treatment of Kawasaki syndrome: a com-parison of two dosage regimens of intravenously administered im-mune globulin. J Pediatr 1990;117:628–44.
   Google Scholar
• Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. Intravenous y-globulin for Kawasaki disease. Acta Paediatr Jpn 1991;33:799–804.
   PubMedGoogle Scholar
• Harada K. Intravenous y-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33:805–10.
   PubMedGoogle Scholar
• Hwang B, Lin CY, Hsieh KS, Tsuei DH, Meng CCL. High-dose intravenous gamma-globulin therapy in Kawasaki disease. Acta Paediatr Sin 1989;30:15–22.
   Google Scholar
• Klassen TP, Rowe PC, Gafni A. Economic evaluation of intrave-nous immune globulin therapy for Kawasaki syndrome. J Pediatr 1993;122:538–42.
   Google Scholar
• Matsushima M, Nagashima M, Matsuoka H, Ogawa A, Okumura N, Itoh S, et al. A controlled study of gamma globulin treatment for Kawasaki disease. J Jpn Pediatr Soc 1986;90:80-7 (in Japanese).
   Google Scholar
• Morikawa Y, Ohashi Y, Harada K, Asai T, Okawa S, Nagashima M, et al. A multicenter, randomized, controlled trial of intravenous gamma globulin therapy in children with acute Kawasaki disease. Acta Paediatr Jpn 1994;36:347–54.
   PubMedGoogle Scholar
• Nagashima M, Matsushima M, Matsuoka H, Ogawa A, Okumura N. High-dose gamma globulin therapy for Kawasaki disease. J Pediatr 1987;110:710–2.
   Google Scholar
• Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intra-venous gamma globulin. N Engl J Med 1986;315:341–7.
   PubMed Web of Science ®Google Scholar
• Ogawa M, Ogino H, Harima Y, Kono S, Ohkuni H, Nishida M, et al. High-dose gamma globulin therapy for Kawasaki disease. J Jpn Pediatr Soc 1987;91:3763-71 (in Japanese).
   Google Scholar
• Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. Clinical evaluation of gamma globulin preparations for the treatment of Kawasaki disease: trial of 200 mg/kg/day for 3 days. J Jpn Pediatr Soc 1987;91:2849-56 (in Japanese).
   Google Scholar
• Okuni M, Harada K, Yamaguchi H, Yanagawa H, Sonobe T, Kawasaki T. Intravenous gamma globulin therapy in Kawasaki disease: trial of low dose gamma globulin. In: Shulman ST, ed. Kawasaki disease. New York: Liss; 1987. p. 433–9.
   Google Scholar
• Onouchi Z, Isogai Y, Yanagisawa M, Yamauchi T, Matsuda H, Morita T, et al. Multicenter randomized controlled study of intra-venous immunoglobulin in Kawasaki disease (in Japanese). J Jpn Pediatr Soc 1988;92:2367–76.
   Google Scholar
• Onouchi Z, Yanagisawa M, Shiraishi H, Hirayama T, Katsube Y, Kiyosawa N, et al. Multicenter randomized controlled study of intravenous immunoglobulin G (C-425) for Kawasaki disease. 1. Study for optimal dosage and usefulness of C-425. J Jpn Pediatr Soc 1992;96:2669-79 (in Japanese).
   Google Scholar
• Tomita Y, Iijima M, Fukaya T, Baba K, Yamakawa M, Hamahata K, et al. Clinical trial of a single intravenous infusion of gamma globulin and its flexible application as compared with five infusions in the treatment of acute Kawasaki disease. J Jpn Pediatr Soc 1995;99:1953-9 (in Japanese).
   Google Scholar
• Yabiku M, Kojima S, Ogawa M, Ogino H, Harima Y, Kono S, et al. High-dose gamma globulin therapy for Kawasaki disease. J Jpn Pediatr Soc 1986;93:2713-20 (in Japanese).
   Google Scholar
• Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The preven-tion of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995;96:1057–61.
   PubMed Web of Science ®Google Scholar
• Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children (Cochrane review). In: The Cochrane Library, Issue 4. Chichester: Wiley; 2003.
   Google Scholar